Core Viewpoint - Pomerantz LLP is investigating claims of potential securities fraud and unlawful business practices by Marex Group PLC following a critical report by NINGI Research that alleges significant financial misconduct [1][3]. Group 1: Investigation and Allegations - Pomerantz LLP is representing investors of Marex Group PLC and is looking into claims of securities fraud or other unlawful practices by the company and its officers [1]. - NINGI Research published a report on August 5, 2025, claiming that Marex has been involved in a multi-year accounting scheme that includes opaque off-balance-sheet entities and misleading disclosures to hide losses and inflate profits [3]. - The report describes Marex as a "financial house of cards," indicating that its balance sheet has significant issues and its financial statements are deemed unreliable [3]. Group 2: Market Reaction - Following the release of the NINGI Research report, Marex's stock price dropped by $2.33, or 6.19%, closing at $35.31 per share on August 5, 2025 [3].

Core Insights - Six Flags Entertainment Corporation is under investigation for potential securities fraud and unlawful business practices [1] - The company reported disappointing Q2 2025 results, lowering its EBITDA guidance significantly [3] - Following the announcement, Six Flags' stock price experienced a substantial decline [4] Financial Performance - Six Flags reduced its EBITDA guidance for the year to between $860 million and $910 million, down from a previous expectation of $1.08 billion to $1.12 billion [3] - The downgrade was attributed to several factors, including first-half results and a smaller season-pass base [3] Management Changes - Richard Zimmerman, the president and CEO of Six Flags, plans to step down from his roles by the end of the year [3] Market Reaction - On August 6, 2025, Six Flags' stock price fell by $6.38 per share, or 20.78%, closing at $24.32 per share [4]

Core Viewpoint - Pomerantz LLP is investigating potential securities fraud or unlawful business practices involving CPI Card Group Inc. and its officers or directors, following disappointing financial results and a significant stock price drop [1][3][4]. Financial Performance - On August 8, 2025, CPI reported second quarter 2025 financial results that missed both top-line and bottom-line estimates, with a GAAP earnings-per-share of $0.04, missing estimates by $0.46, and revenue of $129.75 million, missing estimates by $3.21 million [3]. - The company updated its 2025 outlook, now expecting net sales growth in the low double-digit to mid-teens range, an increase from the previous mid-to-high single-digit growth forecast, attributed to the acquisition of Arroweye Solutions, Inc. [3]. Stock Market Reaction - Following the announcement of the financial results, CPI's stock price fell by $5.37 per share, or 28.83%, closing at $13.25 per share on August 8, 2025 [4].

Group 1 - Pomerantz LLP is investigating claims on behalf of investors of Soleno Therapeutics, Inc. regarding potential securities fraud or unlawful business practices by the company and its officers [1] - Scorpion Capital published a report on August 15, 2025, labeling Soleno's product Vykat XR as overpriced and potentially unsafe for children, leading to a significant stock price drop [3] - Following the Scorpion report, Soleno's stock price decreased by $5.73 per share, or 7.41%, closing at $71.63 per share on the same day [3] Group 2 - Pomerantz LLP is recognized as a leading firm in corporate, securities, and antitrust class litigation, with a history of recovering multimillion-dollar damages for victims of securities fraud [4]

Core Viewpoint - Pomerantz LLP is investigating claims of potential securities fraud or unlawful business practices involving Spirit Aviation Holdings, Inc. following a significant decline in the company's stock price due to concerns about its financial viability [1][3]. Group 1: Company Financial Concerns - On August 11, 2025, Spirit disclosed substantial doubt regarding its ability to continue as a going concern within the next 12 months, citing adverse market conditions and liquidity covenants that require financial results to improve faster than anticipated [3]. - Following this announcement, Spirit's stock price dropped by $1.44 per share, representing a 40.68% decline, closing at $2.10 per share on August 12, 2025 [3]. Group 2: Legal Investigation - Pomerantz LLP is actively investigating whether Spirit and certain officers or directors have engaged in securities fraud or other unlawful business practices, encouraging affected investors to come forward [1].

Core Insights - Pomerantz LLP is investigating claims on behalf of investors of Broadwind, Inc. regarding potential securities fraud or unlawful business practices by the company and its officers [1] - Broadwind reported a GAAP loss per share of $0.04 for Q2 2025, missing consensus estimates by $0.05, and suspended its full-year 2025 financial guidance due to the sale of its industrial fabrication operations [3] - Following the announcement of its financial results, Broadwind's stock price dropped by $0.36, or 14.46%, closing at $2.13 per share on August 12, 2025 [4] Company Financial Performance - Broadwind reported a GAAP loss per share of $0.04 for Q2 2025, which was below the consensus estimate by $0.05 [3] - The company suspended its previously issued full-year 2025 financial guidance due to a definitive agreement to sell its industrial fabrication operations in Manitowoc, Wisconsin [3] Stock Market Reaction - Broadwind's stock price fell by $0.36, representing a 14.46% decrease, closing at $2.13 per share on August 12, 2025, following the financial results announcement [4]

Core Viewpoint - Pomerantz LLP is investigating claims of potential securities fraud and unlawful business practices involving Fly-E Group, Inc. following a report that alleges stock manipulation and safety concerns regarding the company's products [1][3]. Group 1: Investigation Details - Pomerantz LLP is representing investors of Fly-E Group, Inc. and is looking into whether the company and its officers engaged in securities fraud [1]. - The investigation was prompted by a report from The Bear Cave, which claimed that Fly-E's stock is being manipulated and is at risk of a severe collapse [3]. Group 2: Stock Performance - Following the publication of The Bear Cave report, Fly-E's stock price experienced a significant decline over several trading sessions [3]. Group 3: Company Background - Fly-E Group, Inc. is under scrutiny for producing products that are alleged to endanger public safety in New York [3]. - Pomerantz LLP has a long history in corporate and securities class litigation, having recovered numerous multimillion-dollar damages for victims of securities fraud [4].

Core Viewpoint - Pomerantz LLP is investigating potential securities fraud or unlawful business practices involving PubMatic and its executives following disappointing financial guidance and a significant stock price drop [1][2]. Financial Performance - On August 11, 2025, PubMatic announced its Q2 2025 financial results, providing a revenue guidance for Q3 2025 between $61 million and $66 million, which fell short of consensus estimates of $70.77 million [2]. - The disappointing guidance was attributed to an impact from one of PubMatic's top demand-side platform buyers [2]. - Following the announcement, PubMatic's stock price decreased by $2.23 per share, or 21.1%, closing at $8.34 per share on August 12, 2025 [2]. Legal Context - Pomerantz LLP is recognized for its expertise in corporate, securities, and antitrust class litigation, having a long history of fighting for victims of securities fraud and corporate misconduct [3]. - The firm has successfully recovered numerous multimillion-dollar damages awards for class members over its 85-year history [3].

Core Viewpoint - Fluor Corporation is under investigation for potential securities fraud and unlawful business practices following disappointing Q2 2025 financial results and a lowered full-year guidance [1][2]. Financial Performance - On August 1, 2025, Fluor reported Q2 2025 financial results, citing increased costs in infrastructure projects due to subcontractor design errors, price increases, and scheduling delays [2]. - The company also indicated that customers are reducing capital spending, contributing to its lackluster performance [2]. Stock Market Reaction - Following the announcement of its financial results and guidance revision, Fluor's stock price dropped by $15.35 per share, or 27.03%, closing at $41.42 per share on August 5, 2025 [3].

Core Viewpoint - A class action lawsuit has been filed against Altimmune, Inc. for alleged securities fraud and unlawful business practices following disappointing trial results [2][3]. Group 1: Lawsuit Details - The class action lawsuit concerns whether Altimmune and its officers engaged in securities fraud or other unlawful business practices [2]. - Investors who purchased Altimmune securities during the Class Period have until October 6, 2025, to request to be appointed as Lead Plaintiff [3]. Group 2: Trial Results and Market Reaction - On June 26, 2025, Altimmune announced topline results from the IMPACT Phase 2b MASH trial of Pemvidutide, which failed to achieve statistical significance in the primary endpoint of fibrosis reduction [3]. - The trial results showed a positive trend in fibrosis improvement, but a higher-than-expected placebo response led to the lack of statistical significance [3]. - Following the announcement, Altimmune's stock price fell by $4.10 per share, or 53.2%, closing at $3.61 per share [4].